X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$4.11
-2.49%
Mkt Cap $48.03M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $1.73M | $2.57M | +48.18% | -$0.36 | -$0.22 | +38.89% | — | — |
| Q4 2025 Nov 5, 2025 | $1.73M | $1.76M | +1.85% | -$0.79 | -$0.69 | +12.66% | — | — |
| Q3 2025 Aug 8, 2025 | $2.23M | $1.97M | -11.38% | -$4.53 | -$3.47 | +23.40% | — | — |
| Q2 2025 May 1, 2025 | $1.90M | $28.81M | +1416.16% | -$4.13 | $0.04 | +100.97% | — | — |
| Q1 2025 Mar 25, 2025 | $2.23M | $1.43M | -35.82% | -$5.11 | -$6.01 | -17.61% | — | — |
| Q4 2024 Nov 13, 2024 | $1.02M | $560.00K | -44.97% | -$0.17 | -$0.18 | -5.88% | — | — |
| Q3 2024 Aug 8, 2024 | $280.00K | $563.00K | +101.07% | -$0.05 | -$0.07 | -40.00% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.17 | -$0.26 | -52.94% | — | — |
| Q1 2024 Mar 21, 2024 | — | $3.06M | — | -$0.15 | -$0.10 | +33.33% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.15 | -$0.01 | +93.33% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.17 | -$0.33 | -94.12% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.20 | -$0.16 | +20.00% | — | — |
| Q1 2023 Mar 21, 2023 | — | — | — | -$0.23 | -$0.29 | -26.09% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.31 | -$0.26 | +16.13% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.65 | -$0.60 | +7.69% | — | — |
| Q2 2022 May 12, 2022 | $128.57K | — | — | -$0.62 | -$0.72 | -16.13% | — | — |
| Q1 2022 Mar 17, 2022 | — | — | — | -$0.68 | -$1.24 | -82.35% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$0.72 | -$0.76 | -5.56% | — | — |
| Q3 2021 Aug 3, 2021 | — | — | — | -$0.73 | -$0.74 | -1.37% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.84 | -$1.30 | -54.76% | — | — |